Related Experiment Video
Updated: Nov 12, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Diabetes Risk Reduction and Metabolic Surgery.
John D Scott1, Sean C O'Connor2
1Department of Surgery, Division of Minimal Access and Bariatric Surgery, Prisma Health, 905 Verdae Boulevard Suite 202, Greenville, SC 29607, USA.
Metabolic surgery is superior to conventional treatments for type 2 diabetes remission. Increasing access to this procedure improves patient health and global economic well-being.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Surgical Innovation
Background:
- Type 2 diabetes mellitus (T2D) and obesity are rising public health crises.
- T2D complications lead to significant end-organ damage and premature mortality.
- Conventional T2D management includes lifestyle changes, medical therapy, and pharmacotherapy.
Purpose of the Study:
- To evaluate the efficacy of metabolic surgery versus conventional treatments for T2D.
- To highlight metabolic surgery as a superior treatment option for T2D remission.
- To advocate for increased accessibility to metabolic surgery.
Main Methods:
- Comparative analysis of treatment outcomes for T2D.
- Review of recent studies comparing metabolic surgery with non-surgical T2D management.
- Assessment of patient health benefits and macroeconomic impacts.
Main Results:
- Metabolic surgery demonstrates superiority over conventional treatment algorithms for T2D remission.
- Improved patient health outcomes are associated with metabolic surgery.
- Positive macroeconomic effects are linked to wider adoption of metabolic surgery.
Conclusions:
- Metabolic surgery offers a highly effective path to T2D remission.
- Expanding access to metabolic surgery is crucial for public health and economic benefits.
- Metabolic surgery represents a significant advancement in managing T2D and associated conditions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

